UNSPSC 51284004: Demeclocycline

This classification denotes a tetracycline antibiotic with the molecular formula C21H21ClN2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5R5W9ICI6O, chemically known as 7-chloro-4-dimethylamino-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide but generally known as demeclocycline, which bears US NIH Compound Identifier 5281009. European Medicines Agency schedules Demeclocycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06963MIG.

UNSPSC 51284004 Demeclocycline is a Commodity code that appears in state and local procurement activity with limited recent relevance to the code's nominal scope. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for antibiotics including Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—products related to but distinct from Demeclocycline itself. Seminole County, Florida posted an IFB on June 30, 2026, for Naloxone and Safe Drug Deactivation Systems, which falls outside the antibiotic pharmaceutical category entirely. State and local procurement activity under this code shows little alignment between the UNSPSC designation and the work actually being solicited; issuing bodies are using the code tag on acquisitions of broader pharmaceutical products and public health supplies rather than Demeclocycline specifically.

The two recorded recent opportunities span state health departments and county government health and safety programs across Florida and Illinois. The Illinois Department of Public Health contract, valued at $2,999,999.11 over 12 months with renewal options for years 2 and 3, ran through an IFB process with Chartwell Rx LLC selected as the lowest priced responsive and responsible bidder; no set-aside or domestic-preference requirements were applied. Seminole County's IFB, posted with a response deadline of July 26, 2023, seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, potentially funded through FEMA. The code shows narrow recent activity concentrated in these two jurisdictions with no additional state or regional clustering evident from the source.